nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—TGM2—endothelium—systemic scleroderma	0.0158	0.0417	CbGeAlD
L-Glutamine—TGM2—blood vessel—systemic scleroderma	0.0146	0.0384	CbGeAlD
L-Glutamine—TGM6—lung—systemic scleroderma	0.0145	0.0382	CbGeAlD
L-Glutamine—CTPS1—Mycophenolic acid—Mycophenolate mofetil—systemic scleroderma	0.0144	1	CbGdCrCtD
L-Glutamine—TGM2—Beta1 integrin cell surface interactions—FBN1—systemic scleroderma	0.0125	0.0841	CbGpPWpGaD
L-Glutamine—TGM5—skin of body—systemic scleroderma	0.0114	0.03	CbGeAlD
L-Glutamine—TGM2—Beta1 integrin cell surface interactions—TGFBI—systemic scleroderma	0.0109	0.0738	CbGpPWpGaD
L-Glutamine—TGM1—skin of body—systemic scleroderma	0.00921	0.0243	CbGeAlD
L-Glutamine—TGM2—Beta1 integrin cell surface interactions—COL1A2—systemic scleroderma	0.00873	0.0588	CbGpPWpGaD
L-Glutamine—TGM3—skin of body—systemic scleroderma	0.00863	0.0227	CbGeAlD
L-Glutamine—F13A1—Beta1 integrin cell surface interactions—FBN1—systemic scleroderma	0.00843	0.0568	CbGpPWpGaD
L-Glutamine—TGM2—Thromboxane A2 receptor signaling—BLK—systemic scleroderma	0.00836	0.0564	CbGpPWpGaD
L-Glutamine—TGM5—lung—systemic scleroderma	0.00761	0.02	CbGeAlD
L-Glutamine—GLS—connective tissue—systemic scleroderma	0.00756	0.0199	CbGeAlD
L-Glutamine—TGM2—connective tissue—systemic scleroderma	0.00747	0.0197	CbGeAlD
L-Glutamine—F13A1—Beta1 integrin cell surface interactions—TGFBI—systemic scleroderma	0.00739	0.0498	CbGpPWpGaD
L-Glutamine—TGM1—digestive system—systemic scleroderma	0.00737	0.0194	CbGeAlD
L-Glutamine—GMPS—connective tissue—systemic scleroderma	0.00704	0.0185	CbGeAlD
L-Glutamine—TGM3—digestive system—systemic scleroderma	0.0069	0.0182	CbGeAlD
L-Glutamine—TGM2—smooth muscle tissue—systemic scleroderma	0.00684	0.018	CbGeAlD
L-Glutamine—TGM2—skin of body—systemic scleroderma	0.00675	0.0178	CbGeAlD
L-Glutamine—GFPT2—smooth muscle tissue—systemic scleroderma	0.00632	0.0167	CbGeAlD
L-Glutamine—GLS2—digestive system—systemic scleroderma	0.00632	0.0166	CbGeAlD
L-Glutamine—NADSYN1—digestive system—systemic scleroderma	0.00632	0.0166	CbGeAlD
L-Glutamine—F13A1—connective tissue—systemic scleroderma	0.0062	0.0163	CbGeAlD
L-Glutamine—TGM1—lung—systemic scleroderma	0.00615	0.0162	CbGeAlD
L-Glutamine—F13A1—Beta1 integrin cell surface interactions—COL1A2—systemic scleroderma	0.00589	0.0397	CbGpPWpGaD
L-Glutamine—TGM3—lung—systemic scleroderma	0.00577	0.0152	CbGeAlD
L-Glutamine—F13A1—Platelet degranulation—SELP—systemic scleroderma	0.00574	0.0387	CbGpPWpGaD
L-Glutamine—CCBL1—tendon—systemic scleroderma	0.00551	0.0145	CbGeAlD
L-Glutamine—GATB—tendon—systemic scleroderma	0.00551	0.0145	CbGeAlD
L-Glutamine—F13A1—Response to elevated platelet cytosolic Ca2+—SELP—systemic scleroderma	0.00547	0.0369	CbGpPWpGaD
L-Glutamine—GLS—digestive system—systemic scleroderma	0.00546	0.0144	CbGeAlD
L-Glutamine—TGM2—digestive system—systemic scleroderma	0.0054	0.0142	CbGeAlD
L-Glutamine—QARS—smooth muscle tissue—systemic scleroderma	0.00539	0.0142	CbGeAlD
L-Glutamine—QARS—skin of body—systemic scleroderma	0.00532	0.014	CbGeAlD
L-Glutamine—GLS2—lung—systemic scleroderma	0.00527	0.0139	CbGeAlD
L-Glutamine—NADSYN1—lung—systemic scleroderma	0.00527	0.0139	CbGeAlD
L-Glutamine—GLS—tendon—systemic scleroderma	0.00519	0.0137	CbGeAlD
L-Glutamine—CTPS1—digestive system—systemic scleroderma	0.00508	0.0134	CbGeAlD
L-Glutamine—GMPS—digestive system—systemic scleroderma	0.00508	0.0134	CbGeAlD
L-Glutamine—GATB—lung—systemic scleroderma	0.00484	0.0128	CbGeAlD
L-Glutamine—CCBL1—lung—systemic scleroderma	0.00484	0.0128	CbGeAlD
L-Glutamine—GMPS—tendon—systemic scleroderma	0.00484	0.0127	CbGeAlD
L-Glutamine—CTPS1—tendon—systemic scleroderma	0.00484	0.0127	CbGeAlD
L-Glutamine—L-Arginine—NOS3—systemic scleroderma	0.00478	0.54	CrCbGaD
L-Glutamine—PFAS—tendon—systemic scleroderma	0.00475	0.0125	CbGeAlD
L-Glutamine—GFPT2—tendon—systemic scleroderma	0.00475	0.0125	CbGeAlD
L-Glutamine—CAD—Endothelin Pathways—EDN1—systemic scleroderma	0.00472	0.0319	CbGpPWpGaD
L-Glutamine—SLC1A5—connective tissue—systemic scleroderma	0.00467	0.0123	CbGeAlD
L-Glutamine—GLS—lung—systemic scleroderma	0.00456	0.012	CbGeAlD
L-Glutamine—TGM2—lung—systemic scleroderma	0.00451	0.0119	CbGeAlD
L-Glutamine—F13A1—digestive system—systemic scleroderma	0.00448	0.0118	CbGeAlD
L-Glutamine—SLC1A5—smooth muscle tissue—systemic scleroderma	0.00427	0.0113	CbGeAlD
L-Glutamine—F13A1—tendon—systemic scleroderma	0.00426	0.0112	CbGeAlD
L-Glutamine—QARS—digestive system—systemic scleroderma	0.00426	0.0112	CbGeAlD
L-Glutamine—CTPS1—lung—systemic scleroderma	0.00425	0.0112	CbGeAlD
L-Glutamine—GMPS—lung—systemic scleroderma	0.00425	0.0112	CbGeAlD
L-Glutamine—SLC1A5—skin of body—systemic scleroderma	0.00422	0.0111	CbGeAlD
L-Glutamine—PFAS—lung—systemic scleroderma	0.00417	0.011	CbGeAlD
L-Glutamine—GFPT2—lung—systemic scleroderma	0.00417	0.011	CbGeAlD
L-Glutamine—L-Citrulline—NOS3—systemic scleroderma	0.00406	0.46	CrCbGaD
L-Glutamine—QARS—tendon—systemic scleroderma	0.00405	0.0107	CbGeAlD
L-Glutamine—SLC7A8—skin of body—systemic scleroderma	0.0038	0.01	CbGeAlD
L-Glutamine—F13A1—lung—systemic scleroderma	0.00374	0.00986	CbGeAlD
L-Glutamine—CAD—tendon—systemic scleroderma	0.00374	0.00985	CbGeAlD
L-Glutamine—ASNS—smooth muscle tissue—systemic scleroderma	0.00366	0.00965	CbGeAlD
L-Glutamine—QARS—lung—systemic scleroderma	0.00356	0.00937	CbGeAlD
L-Glutamine—PPAT—tendon—systemic scleroderma	0.00347	0.00913	CbGeAlD
L-Glutamine—SLC1A5—digestive system—systemic scleroderma	0.00337	0.00888	CbGeAlD
L-Glutamine—SLC7A8—Basigin interactions—MMP1—systemic scleroderma	0.00335	0.0226	CbGpPWpGaD
L-Glutamine—TGM2—Thromboxane A2 receptor signaling—NOS3—systemic scleroderma	0.00328	0.0221	CbGpPWpGaD
L-Glutamine—CAD—lung—systemic scleroderma	0.00328	0.00864	CbGeAlD
L-Glutamine—GLUL—connective tissue—systemic scleroderma	0.00327	0.00862	CbGeAlD
L-Glutamine—SLC1A5—tendon—systemic scleroderma	0.00321	0.00846	CbGeAlD
L-Glutamine—PPAT—lung—systemic scleroderma	0.00304	0.00801	CbGeAlD
L-Glutamine—GLUL—smooth muscle tissue—systemic scleroderma	0.00299	0.00788	CbGeAlD
L-Glutamine—GLUL—skin of body—systemic scleroderma	0.00295	0.00778	CbGeAlD
L-Glutamine—SLC7A8—tendon—systemic scleroderma	0.00289	0.00761	CbGeAlD
L-Glutamine—CAD—Endothelin Pathways—NOS3—systemic scleroderma	0.00288	0.0194	CbGpPWpGaD
L-Glutamine—ASNS—ATF4 activates genes—CCL2—systemic scleroderma	0.00287	0.0194	CbGpPWpGaD
L-Glutamine—SLC1A5—lung—systemic scleroderma	0.00282	0.00742	CbGeAlD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—SELP—systemic scleroderma	0.00278	0.0187	CbGpPWpGaD
L-Glutamine—ASNS—tendon—systemic scleroderma	0.00275	0.00725	CbGeAlD
L-Glutamine—ASNS—PERK regulates gene expression—CCL2—systemic scleroderma	0.00262	0.0177	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	0.00255	0.0172	CbGpPWpGaD
L-Glutamine—SLC7A8—lung—systemic scleroderma	0.00254	0.00668	CbGeAlD
L-Glutamine—ASNS—lung—systemic scleroderma	0.00242	0.00637	CbGeAlD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	0.00238	0.016	CbGpPWpGaD
L-Glutamine—GLUL—digestive system—systemic scleroderma	0.00236	0.00623	CbGeAlD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—TNFAIP3—systemic scleroderma	0.00233	0.0157	CbGpPWpGaD
L-Glutamine—GLUL—tendon—systemic scleroderma	0.00225	0.00592	CbGeAlD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—ITGAM—systemic scleroderma	0.00222	0.015	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	0.00217	0.0146	CbGpPWpGaD
L-Glutamine—GLUL—lung—systemic scleroderma	0.00197	0.0052	CbGeAlD
L-Glutamine—SLC16A10—tendon—systemic scleroderma	0.00171	0.00452	CbGeAlD
L-Glutamine—SLC16A10—lung—systemic scleroderma	0.0015	0.00396	CbGeAlD
L-Glutamine—F13A1—Hemostasis—SELP—systemic scleroderma	0.00131	0.00885	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—RHOB—systemic scleroderma	0.00123	0.00826	CbGpPWpGaD
L-Glutamine—Mental disorder—Mycophenolic acid—systemic scleroderma	0.00121	0.00269	CcSEcCtD
L-Glutamine—Malaise—Azathioprine—systemic scleroderma	0.0012	0.00268	CcSEcCtD
L-Glutamine—Malnutrition—Mycophenolic acid—systemic scleroderma	0.0012	0.00267	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00265	CcSEcCtD
L-Glutamine—Flatulence—Mycophenolic acid—systemic scleroderma	0.00118	0.00263	CcSEcCtD
L-Glutamine—Asthenia—Pentoxifylline—systemic scleroderma	0.00118	0.00263	CcSEcCtD
L-Glutamine—Ill-defined disorder—Leflunomide—systemic scleroderma	0.00117	0.0026	CcSEcCtD
L-Glutamine—Pruritus—Pentoxifylline—systemic scleroderma	0.00116	0.00259	CcSEcCtD
L-Glutamine—Back pain—Mycophenolic acid—systemic scleroderma	0.00116	0.00259	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00116	0.00258	CcSEcCtD
L-Glutamine—ASNS—Unfolded Protein Response (UPR)—CCL2—systemic scleroderma	0.00116	0.0078	CbGpPWpGaD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—MMP9—systemic scleroderma	0.00115	0.00775	CbGpPWpGaD
L-Glutamine—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00114	0.00253	CcSEcCtD
L-Glutamine—Malaise—Leflunomide—systemic scleroderma	0.00113	0.00253	CcSEcCtD
L-Glutamine—Myalgia—Azathioprine—systemic scleroderma	0.00113	0.00253	CcSEcCtD
L-Glutamine—Arthralgia—Azathioprine—systemic scleroderma	0.00113	0.00253	CcSEcCtD
L-Glutamine—Insomnia—Captopril—systemic scleroderma	0.00113	0.00251	CcSEcCtD
L-Glutamine—Angiopathy—Lisinopril—systemic scleroderma	0.00113	0.00251	CcSEcCtD
L-Glutamine—Body temperature increased—Mometasone—systemic scleroderma	0.00112	0.0025	CcSEcCtD
L-Glutamine—Abdominal pain—Mometasone—systemic scleroderma	0.00112	0.0025	CcSEcCtD
L-Glutamine—Discomfort—Azathioprine—systemic scleroderma	0.00112	0.0025	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—CSK—systemic scleroderma	0.00112	0.00753	CbGpPWpGaD
L-Glutamine—Chills—Lisinopril—systemic scleroderma	0.00111	0.00248	CcSEcCtD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—MMP1—systemic scleroderma	0.00111	0.00751	CbGpPWpGaD
L-Glutamine—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00111	0.00248	CcSEcCtD
L-Glutamine—F13A1—Platelet degranulation—TGFB1—systemic scleroderma	0.0011	0.00743	CbGpPWpGaD
L-Glutamine—Rhinitis—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00243	CcSEcCtD
L-Glutamine—QARS—Gene Expression—SMAD7—systemic scleroderma	0.00109	0.00735	CbGpPWpGaD
L-Glutamine—Mental disorder—Lisinopril—systemic scleroderma	0.00109	0.00242	CcSEcCtD
L-Glutamine—Dizziness—Pentoxifylline—systemic scleroderma	0.00109	0.00242	CcSEcCtD
L-Glutamine—Malaise—Mycophenolic acid—systemic scleroderma	0.00108	0.00241	CcSEcCtD
L-Glutamine—Malnutrition—Lisinopril—systemic scleroderma	0.00108	0.00241	CcSEcCtD
L-Glutamine—Infection—Azathioprine—systemic scleroderma	0.00108	0.00241	CcSEcCtD
L-Glutamine—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00241	CcSEcCtD
L-Glutamine—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00239	CcSEcCtD
L-Glutamine—Fatigue—Captopril—systemic scleroderma	0.00107	0.00239	CcSEcCtD
L-Glutamine—Arthralgia—Leflunomide—systemic scleroderma	0.00107	0.00239	CcSEcCtD
L-Glutamine—Chest pain—Leflunomide—systemic scleroderma	0.00107	0.00239	CcSEcCtD
L-Glutamine—Myalgia—Leflunomide—systemic scleroderma	0.00107	0.00239	CcSEcCtD
L-Glutamine—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00238	CcSEcCtD
L-Glutamine—Constipation—Captopril—systemic scleroderma	0.00107	0.00237	CcSEcCtD
L-Glutamine—Flatulence—Lisinopril—systemic scleroderma	0.00107	0.00237	CcSEcCtD
L-Glutamine—Sepsis—Methotrexate—systemic scleroderma	0.00107	0.00237	CcSEcCtD
L-Glutamine—Discomfort—Leflunomide—systemic scleroderma	0.00106	0.00236	CcSEcCtD
L-Glutamine—F13A1—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	0.00105	0.00708	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—ITGAM—systemic scleroderma	0.00105	0.00708	CbGpPWpGaD
L-Glutamine—Dry mouth—Leflunomide—systemic scleroderma	0.00105	0.00233	CcSEcCtD
L-Glutamine—Back pain—Lisinopril—systemic scleroderma	0.00105	0.00233	CcSEcCtD
L-Glutamine—Vomiting—Pentoxifylline—systemic scleroderma	0.00105	0.00233	CcSEcCtD
L-Glutamine—Rash—Pentoxifylline—systemic scleroderma	0.00104	0.00231	CcSEcCtD
L-Glutamine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00104	0.00231	CcSEcCtD
L-Glutamine—Headache—Pentoxifylline—systemic scleroderma	0.00103	0.00229	CcSEcCtD
L-Glutamine—Feeling abnormal—Captopril—systemic scleroderma	0.00103	0.00229	CcSEcCtD
L-Glutamine—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00102	0.00228	CcSEcCtD
L-Glutamine—Chest pain—Mycophenolic acid—systemic scleroderma	0.00102	0.00228	CcSEcCtD
L-Glutamine—Myalgia—Mycophenolic acid—systemic scleroderma	0.00102	0.00228	CcSEcCtD
L-Glutamine—Infection—Leflunomide—systemic scleroderma	0.00102	0.00227	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Captopril—systemic scleroderma	0.00102	0.00227	CcSEcCtD
L-Glutamine—Asthenia—Mometasone—systemic scleroderma	0.00102	0.00227	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—CCL2—systemic scleroderma	0.00101	0.00683	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—TNFSF13—systemic scleroderma	0.00101	0.00683	CbGpPWpGaD
L-Glutamine—Discomfort—Mycophenolic acid—systemic scleroderma	0.00101	0.00225	CcSEcCtD
L-Glutamine—Pruritus—Mometasone—systemic scleroderma	0.001	0.00224	CcSEcCtD
L-Glutamine—Ill-defined disorder—Lisinopril—systemic scleroderma	0.001	0.00223	CcSEcCtD
L-Glutamine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000999	0.00223	CcSEcCtD
L-Glutamine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000993	0.00221	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000991	0.00221	CcSEcCtD
L-Glutamine—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000987	0.0022	CcSEcCtD
L-Glutamine—Abdominal pain—Captopril—systemic scleroderma	0.000985	0.00219	CcSEcCtD
L-Glutamine—Body temperature increased—Captopril—systemic scleroderma	0.000985	0.00219	CcSEcCtD
L-Glutamine—Oedema—Mycophenolic acid—systemic scleroderma	0.00098	0.00218	CcSEcCtD
L-Glutamine—Nausea—Pentoxifylline—systemic scleroderma	0.000977	0.00218	CcSEcCtD
L-Glutamine—Chills—Mycophenolate mofetil—systemic scleroderma	0.000976	0.00217	CcSEcCtD
L-Glutamine—Malaise—Lisinopril—systemic scleroderma	0.000975	0.00217	CcSEcCtD
L-Glutamine—Infection—Mycophenolic acid—systemic scleroderma	0.000973	0.00217	CcSEcCtD
L-Glutamine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000953	0.00212	CcSEcCtD
L-Glutamine—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000947	0.00211	CcSEcCtD
L-Glutamine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000947	0.00211	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000936	0.00208	CcSEcCtD
L-Glutamine—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000934	0.00208	CcSEcCtD
L-Glutamine—Insomnia—Leflunomide—systemic scleroderma	0.000929	0.00207	CcSEcCtD
L-Glutamine—Abdominal distension—Prednisone—systemic scleroderma	0.000928	0.00207	CcSEcCtD
L-Glutamine—NADSYN1—Disease—SMAD7—systemic scleroderma	0.000925	0.00624	CbGpPWpGaD
L-Glutamine—Chest pain—Lisinopril—systemic scleroderma	0.000921	0.00205	CcSEcCtD
L-Glutamine—Myalgia—Lisinopril—systemic scleroderma	0.000921	0.00205	CcSEcCtD
L-Glutamine—Arthralgia—Lisinopril—systemic scleroderma	0.000921	0.00205	CcSEcCtD
L-Glutamine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000916	0.00204	CcSEcCtD
L-Glutamine—Discomfort—Lisinopril—systemic scleroderma	0.000909	0.00203	CcSEcCtD
L-Glutamine—Pancreatitis—Prednisone—systemic scleroderma	0.000904	0.00201	CcSEcCtD
L-Glutamine—Vomiting—Mometasone—systemic scleroderma	0.000902	0.00201	CcSEcCtD
L-Glutamine—Dry mouth—Lisinopril—systemic scleroderma	0.0009	0.00201	CcSEcCtD
L-Glutamine—Sweating increased—Prednisone—systemic scleroderma	0.000898	0.002	CcSEcCtD
L-Glutamine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000896	0.002	CcSEcCtD
L-Glutamine—Rash—Mometasone—systemic scleroderma	0.000895	0.00199	CcSEcCtD
L-Glutamine—Asthenia—Captopril—systemic scleroderma	0.000894	0.00199	CcSEcCtD
L-Glutamine—Dermatitis—Mometasone—systemic scleroderma	0.000894	0.00199	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000893	0.00199	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000889	0.00198	CcSEcCtD
L-Glutamine—Headache—Mometasone—systemic scleroderma	0.000889	0.00198	CcSEcCtD
L-Glutamine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000886	0.00197	CcSEcCtD
L-Glutamine—Fatigue—Leflunomide—systemic scleroderma	0.000885	0.00197	CcSEcCtD
L-Glutamine—Oedema—Lisinopril—systemic scleroderma	0.000882	0.00197	CcSEcCtD
L-Glutamine—Pruritus—Captopril—systemic scleroderma	0.000882	0.00196	CcSEcCtD
L-Glutamine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000879	0.00196	CcSEcCtD
L-Glutamine—Constipation—Leflunomide—systemic scleroderma	0.000878	0.00196	CcSEcCtD
L-Glutamine—Pain—Leflunomide—systemic scleroderma	0.000878	0.00196	CcSEcCtD
L-Glutamine—Infection—Lisinopril—systemic scleroderma	0.000877	0.00195	CcSEcCtD
L-Glutamine—Abdominal pain—Azathioprine—systemic scleroderma	0.00086	0.00191	CcSEcCtD
L-Glutamine—Body temperature increased—Azathioprine—systemic scleroderma	0.00086	0.00191	CcSEcCtD
L-Glutamine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000854	0.0019	CcSEcCtD
L-Glutamine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000853	0.0019	CcSEcCtD
L-Glutamine—NADSYN1—Disease—TGFBI—systemic scleroderma	0.000846	0.00571	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000846	0.00188	CcSEcCtD
L-Glutamine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000845	0.00188	CcSEcCtD
L-Glutamine—Nausea—Mometasone—systemic scleroderma	0.000843	0.00188	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00084	0.00187	CcSEcCtD
L-Glutamine—Pain—Mycophenolic acid—systemic scleroderma	0.000838	0.00187	CcSEcCtD
L-Glutamine—Constipation—Mycophenolic acid—systemic scleroderma	0.000838	0.00187	CcSEcCtD
L-Glutamine—Dizziness—Captopril—systemic scleroderma	0.000824	0.00184	CcSEcCtD
L-Glutamine—Depression—Prednisone—systemic scleroderma	0.000819	0.00183	CcSEcCtD
L-Glutamine—Abdominal pain—Leflunomide—systemic scleroderma	0.000812	0.00181	CcSEcCtD
L-Glutamine—Body temperature increased—Leflunomide—systemic scleroderma	0.000812	0.00181	CcSEcCtD
L-Glutamine—CCBL1—Disease—SMAD7—systemic scleroderma	0.000809	0.00545	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000807	0.0018	CcSEcCtD
L-Glutamine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000807	0.0018	CcSEcCtD
L-Glutamine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000807	0.0018	CcSEcCtD
L-Glutamine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000807	0.0018	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000805	0.00179	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000804	0.00179	CcSEcCtD
L-Glutamine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000801	0.00178	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000801	0.00178	CcSEcCtD
L-Glutamine—Insomnia—Lisinopril—systemic scleroderma	0.000798	0.00178	CcSEcCtD
L-Glutamine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000797	0.00177	CcSEcCtD
L-Glutamine—Vomiting—Captopril—systemic scleroderma	0.000792	0.00176	CcSEcCtD
L-Glutamine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000789	0.00176	CcSEcCtD
L-Glutamine—Rash—Captopril—systemic scleroderma	0.000786	0.00175	CcSEcCtD
L-Glutamine—Dermatitis—Captopril—systemic scleroderma	0.000785	0.00175	CcSEcCtD
L-Glutamine—Headache—Captopril—systemic scleroderma	0.000781	0.00174	CcSEcCtD
L-Glutamine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000774	0.00173	CcSEcCtD
L-Glutamine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000774	0.00173	CcSEcCtD
L-Glutamine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000773	0.00172	CcSEcCtD
L-Glutamine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000768	0.00171	CcSEcCtD
L-Glutamine—Fatigue—Lisinopril—systemic scleroderma	0.000761	0.00169	CcSEcCtD
L-Glutamine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000757	0.00169	CcSEcCtD
L-Glutamine—Pancreatitis—Methotrexate—systemic scleroderma	0.000755	0.00168	CcSEcCtD
L-Glutamine—Pain—Lisinopril—systemic scleroderma	0.000755	0.00168	CcSEcCtD
L-Glutamine—Constipation—Lisinopril—systemic scleroderma	0.000755	0.00168	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—SELP—systemic scleroderma	0.000754	0.00508	CbGpPWpGaD
L-Glutamine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000747	0.00166	CcSEcCtD
L-Glutamine—Nausea—Captopril—systemic scleroderma	0.00074	0.00165	CcSEcCtD
L-Glutamine—CCBL1—Disease—TGFBI—systemic scleroderma	0.00074	0.00499	CbGpPWpGaD
L-Glutamine—Asthenia—Leflunomide—systemic scleroderma	0.000737	0.00164	CcSEcCtD
L-Glutamine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000727	0.00162	CcSEcCtD
L-Glutamine—Pruritus—Leflunomide—systemic scleroderma	0.000727	0.00162	CcSEcCtD
L-Glutamine—GFPT2—Metabolism of proteins—ACE—systemic scleroderma	0.000723	0.00487	CbGpPWpGaD
L-Glutamine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000722	0.00161	CcSEcCtD
L-Glutamine—Dizziness—Azathioprine—systemic scleroderma	0.000719	0.0016	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000704	0.00157	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—RHOB—systemic scleroderma	0.000704	0.00475	CbGpPWpGaD
L-Glutamine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000703	0.00157	CcSEcCtD
L-Glutamine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000699	0.00156	CcSEcCtD
L-Glutamine—Body temperature increased—Lisinopril—systemic scleroderma	0.000698	0.00155	CcSEcCtD
L-Glutamine—Abdominal pain—Lisinopril—systemic scleroderma	0.000698	0.00155	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—HSPG2—systemic scleroderma	0.000694	0.00468	CbGpPWpGaD
L-Glutamine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000693	0.00154	CcSEcCtD
L-Glutamine—Vomiting—Azathioprine—systemic scleroderma	0.000691	0.00154	CcSEcCtD
L-Glutamine—Rash—Azathioprine—systemic scleroderma	0.000686	0.00153	CcSEcCtD
L-Glutamine—Dermatitis—Azathioprine—systemic scleroderma	0.000685	0.00153	CcSEcCtD
L-Glutamine—Depression—Methotrexate—systemic scleroderma	0.000685	0.00153	CcSEcCtD
L-Glutamine—Headache—Azathioprine—systemic scleroderma	0.000681	0.00152	CcSEcCtD
L-Glutamine—Dizziness—Leflunomide—systemic scleroderma	0.000679	0.00151	CcSEcCtD
L-Glutamine—NADSYN1—Disease—HSPG2—systemic scleroderma	0.000675	0.00455	CbGpPWpGaD
L-Glutamine—Angiopathy—Prednisone—systemic scleroderma	0.000669	0.00149	CcSEcCtD
L-Glutamine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000661	0.00147	CcSEcCtD
L-Glutamine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000661	0.00147	CcSEcCtD
L-Glutamine—Vomiting—Leflunomide—systemic scleroderma	0.000653	0.00145	CcSEcCtD
L-Glutamine—NADSYN1—Disease—CSK—systemic scleroderma	0.000652	0.0044	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00065	0.00145	CcSEcCtD
L-Glutamine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000648	0.00144	CcSEcCtD
L-Glutamine—Rash—Leflunomide—systemic scleroderma	0.000648	0.00144	CcSEcCtD
L-Glutamine—Dermatitis—Leflunomide—systemic scleroderma	0.000647	0.00144	CcSEcCtD
L-Glutamine—Mental disorder—Prednisone—systemic scleroderma	0.000646	0.00144	CcSEcCtD
L-Glutamine—Nausea—Azathioprine—systemic scleroderma	0.000646	0.00144	CcSEcCtD
L-Glutamine—Headache—Leflunomide—systemic scleroderma	0.000643	0.00143	CcSEcCtD
L-Glutamine—Malnutrition—Prednisone—systemic scleroderma	0.000642	0.00143	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—CSK—systemic scleroderma	0.000641	0.00432	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000637	0.00142	CcSEcCtD
L-Glutamine—Asthenia—Lisinopril—systemic scleroderma	0.000633	0.00141	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000632	0.00141	CcSEcCtD
L-Glutamine—Pruritus—Lisinopril—systemic scleroderma	0.000624	0.00139	CcSEcCtD
L-Glutamine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000623	0.00139	CcSEcCtD
L-Glutamine—GMPS—Metabolism—HSPG2—systemic scleroderma	0.000618	0.00417	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—HSPG2—systemic scleroderma	0.000618	0.00417	CbGpPWpGaD
L-Glutamine—Rash—Mycophenolic acid—systemic scleroderma	0.000618	0.00138	CcSEcCtD
L-Glutamine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000617	0.00137	CcSEcCtD
L-Glutamine—Headache—Mycophenolic acid—systemic scleroderma	0.000614	0.00137	CcSEcCtD
L-Glutamine—NADSYN1—Disease—CD247—systemic scleroderma	0.000613	0.00413	CbGpPWpGaD
L-Glutamine—Pharyngitis—Methotrexate—systemic scleroderma	0.000612	0.00136	CcSEcCtD
L-Glutamine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000611	0.00136	CcSEcCtD
L-Glutamine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000611	0.00136	CcSEcCtD
L-Glutamine—Nausea—Leflunomide—systemic scleroderma	0.00061	0.00136	CcSEcCtD
L-Glutamine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000609	0.00136	CcSEcCtD
L-Glutamine—Urethral disorder—Methotrexate—systemic scleroderma	0.000604	0.00135	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—ITGAM—systemic scleroderma	0.000603	0.00406	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—CTGF—systemic scleroderma	0.000603	0.00406	CbGpPWpGaD
L-Glutamine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000596	0.00133	CcSEcCtD
L-Glutamine—CCBL1—Disease—HSPG2—systemic scleroderma	0.00059	0.00398	CbGpPWpGaD
L-Glutamine—Dizziness—Lisinopril—systemic scleroderma	0.000584	0.0013	CcSEcCtD
L-Glutamine—Nausea—Mycophenolic acid—systemic scleroderma	0.000582	0.0013	CcSEcCtD
L-Glutamine—Malaise—Prednisone—systemic scleroderma	0.000579	0.00129	CcSEcCtD
L-Glutamine—CCBL1—Disease—CSK—systemic scleroderma	0.00057	0.00384	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00057	0.00127	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—HSPG2—systemic scleroderma	0.000565	0.00381	CbGpPWpGaD
L-Glutamine—Vomiting—Lisinopril—systemic scleroderma	0.000561	0.00125	CcSEcCtD
L-Glutamine—Angiopathy—Methotrexate—systemic scleroderma	0.000559	0.00125	CcSEcCtD
L-Glutamine—Rash—Lisinopril—systemic scleroderma	0.000556	0.00124	CcSEcCtD
L-Glutamine—Dermatitis—Lisinopril—systemic scleroderma	0.000556	0.00124	CcSEcCtD
L-Glutamine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000555	0.00124	CcSEcCtD
L-Glutamine—Chills—Methotrexate—systemic scleroderma	0.000553	0.00123	CcSEcCtD
L-Glutamine—Headache—Lisinopril—systemic scleroderma	0.000553	0.00123	CcSEcCtD
L-Glutamine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000547	0.00122	CcSEcCtD
L-Glutamine—Myalgia—Prednisone—systemic scleroderma	0.000547	0.00122	CcSEcCtD
L-Glutamine—Arthralgia—Prednisone—systemic scleroderma	0.000547	0.00122	CcSEcCtD
L-Glutamine—Discomfort—Prednisone—systemic scleroderma	0.00054	0.0012	CcSEcCtD
L-Glutamine—Mental disorder—Methotrexate—systemic scleroderma	0.00054	0.0012	CcSEcCtD
L-Glutamine—Malnutrition—Methotrexate—systemic scleroderma	0.000537	0.0012	CcSEcCtD
L-Glutamine—CCBL1—Disease—CD247—systemic scleroderma	0.000536	0.00361	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—MMP1—systemic scleroderma	0.000526	0.00355	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—CTGF—systemic scleroderma	0.000526	0.00354	CbGpPWpGaD
L-Glutamine—Nausea—Lisinopril—systemic scleroderma	0.000524	0.00117	CcSEcCtD
L-Glutamine—Oedema—Prednisone—systemic scleroderma	0.000524	0.00117	CcSEcCtD
L-Glutamine—Infection—Prednisone—systemic scleroderma	0.000521	0.00116	CcSEcCtD
L-Glutamine—Back pain—Methotrexate—systemic scleroderma	0.000519	0.00116	CcSEcCtD
L-Glutamine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000511	0.00114	CcSEcCtD
L-Glutamine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000507	0.00113	CcSEcCtD
L-Glutamine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000498	0.00111	CcSEcCtD
L-Glutamine—GLS—Metabolism—HSPG2—systemic scleroderma	0.000494	0.00333	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—HSPG2—systemic scleroderma	0.000494	0.00333	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—HSPG2—systemic scleroderma	0.000494	0.00333	CbGpPWpGaD
L-Glutamine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000492	0.00109	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.000489	0.0033	CbGpPWpGaD
L-Glutamine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000487	0.00109	CcSEcCtD
L-Glutamine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000487	0.00108	CcSEcCtD
L-Glutamine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000484	0.00108	CcSEcCtD
L-Glutamine—Malaise—Methotrexate—systemic scleroderma	0.000484	0.00108	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000477	0.00106	CcSEcCtD
L-Glutamine—Insomnia—Prednisone—systemic scleroderma	0.000474	0.00106	CcSEcCtD
L-Glutamine—PFAS—Metabolism—CTGF—systemic scleroderma	0.000469	0.00316	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—CTGF—systemic scleroderma	0.000469	0.00316	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—MMP1—systemic scleroderma	0.000464	0.00313	CbGpPWpGaD
L-Glutamine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000459	0.00102	CcSEcCtD
L-Glutamine—Arthralgia—Methotrexate—systemic scleroderma	0.000457	0.00102	CcSEcCtD
L-Glutamine—Chest pain—Methotrexate—systemic scleroderma	0.000457	0.00102	CcSEcCtD
L-Glutamine—Myalgia—Methotrexate—systemic scleroderma	0.000457	0.00102	CcSEcCtD
L-Glutamine—Fatigue—Prednisone—systemic scleroderma	0.000452	0.00101	CcSEcCtD
L-Glutamine—Discomfort—Methotrexate—systemic scleroderma	0.000451	0.00101	CcSEcCtD
L-Glutamine—Constipation—Prednisone—systemic scleroderma	0.000448	0.000998	CcSEcCtD
L-Glutamine—Infection—Methotrexate—systemic scleroderma	0.000435	0.000969	CcSEcCtD
L-Glutamine—Feeling abnormal—Prednisone—systemic scleroderma	0.000432	0.000962	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000429	0.000955	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—CTGF—systemic scleroderma	0.000429	0.00289	CbGpPWpGaD
L-Glutamine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000423	0.000943	CcSEcCtD
L-Glutamine—Abdominal pain—Prednisone—systemic scleroderma	0.000414	0.000923	CcSEcCtD
L-Glutamine—Body temperature increased—Prednisone—systemic scleroderma	0.000414	0.000923	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000399	0.000889	CcSEcCtD
L-Glutamine—CAD—Metabolism—HSPG2—systemic scleroderma	0.000398	0.00269	CbGpPWpGaD
L-Glutamine—Insomnia—Methotrexate—systemic scleroderma	0.000396	0.000882	CcSEcCtD
L-Glutamine—ASNS—Metabolism of proteins—ACE—systemic scleroderma	0.00039	0.00263	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Prednisone—systemic scleroderma	0.000386	0.00086	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—NOS3—systemic scleroderma	0.000381	0.00257	CbGpPWpGaD
L-Glutamine—Fatigue—Methotrexate—systemic scleroderma	0.000378	0.000841	CcSEcCtD
L-Glutamine—GFPT2—Metabolism of proteins—CCL2—systemic scleroderma	0.000377	0.00255	CbGpPWpGaD
L-Glutamine—Asthenia—Prednisone—systemic scleroderma	0.000376	0.000838	CcSEcCtD
L-Glutamine—GLS2—Metabolism—CTGF—systemic scleroderma	0.000375	0.00253	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—CTGF—systemic scleroderma	0.000375	0.00253	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CTGF—systemic scleroderma	0.000375	0.00253	CbGpPWpGaD
L-Glutamine—Pain—Methotrexate—systemic scleroderma	0.000375	0.000834	CcSEcCtD
L-Glutamine—Pruritus—Prednisone—systemic scleroderma	0.000371	0.000826	CcSEcCtD
L-Glutamine—PPAT—Metabolism—HSPG2—systemic scleroderma	0.000364	0.00246	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000361	0.000804	CcSEcCtD
L-Glutamine—GFPT2—Metabolism of proteins—MMP2—systemic scleroderma	0.000359	0.00242	CbGpPWpGaD
L-Glutamine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000358	0.000798	CcSEcCtD
L-Glutamine—Dizziness—Prednisone—systemic scleroderma	0.000347	0.000772	CcSEcCtD
L-Glutamine—Body temperature increased—Methotrexate—systemic scleroderma	0.000346	0.000771	CcSEcCtD
L-Glutamine—Abdominal pain—Methotrexate—systemic scleroderma	0.000346	0.000771	CcSEcCtD
L-Glutamine—Vomiting—Prednisone—systemic scleroderma	0.000333	0.000742	CcSEcCtD
L-Glutamine—Rash—Prednisone—systemic scleroderma	0.00033	0.000736	CcSEcCtD
L-Glutamine—Dermatitis—Prednisone—systemic scleroderma	0.00033	0.000735	CcSEcCtD
L-Glutamine—Headache—Prednisone—systemic scleroderma	0.000328	0.000731	CcSEcCtD
L-Glutamine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000323	0.000719	CcSEcCtD
L-Glutamine—Asthenia—Methotrexate—systemic scleroderma	0.000314	0.0007	CcSEcCtD
L-Glutamine—Nausea—Prednisone—systemic scleroderma	0.000311	0.000693	CcSEcCtD
L-Glutamine—Pruritus—Methotrexate—systemic scleroderma	0.00031	0.00069	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—MMP1—systemic scleroderma	0.000302	0.00204	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—CTGF—systemic scleroderma	0.000302	0.00204	CbGpPWpGaD
L-Glutamine—Dizziness—Methotrexate—systemic scleroderma	0.00029	0.000645	CcSEcCtD
L-Glutamine—GLUL—Metabolism—HSPG2—systemic scleroderma	0.000284	0.00191	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—HSPG2—systemic scleroderma	0.000284	0.00191	CbGpPWpGaD
L-Glutamine—Vomiting—Methotrexate—systemic scleroderma	0.000278	0.00062	CcSEcCtD
L-Glutamine—Rash—Methotrexate—systemic scleroderma	0.000276	0.000615	CcSEcCtD
L-Glutamine—PPAT—Metabolism—CTGF—systemic scleroderma	0.000276	0.00186	CbGpPWpGaD
L-Glutamine—Dermatitis—Methotrexate—systemic scleroderma	0.000276	0.000615	CcSEcCtD
L-Glutamine—Headache—Methotrexate—systemic scleroderma	0.000274	0.000611	CcSEcCtD
L-Glutamine—Nausea—Methotrexate—systemic scleroderma	0.00026	0.000579	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—TGFB1—systemic scleroderma	0.000252	0.0017	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—MMP1—systemic scleroderma	0.000251	0.00169	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—NOS3—systemic scleroderma	0.000229	0.00154	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—NOS3—systemic scleroderma	0.000223	0.0015	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—NOS3—systemic scleroderma	0.000219	0.00148	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CTGF—systemic scleroderma	0.000215	0.00145	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CTGF—systemic scleroderma	0.000215	0.00145	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—NOS3—systemic scleroderma	0.000204	0.00138	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—NOS3—systemic scleroderma	0.000204	0.00138	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CCL2—systemic scleroderma	0.000204	0.00137	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NOS3—systemic scleroderma	0.000195	0.00131	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—MMP2—systemic scleroderma	0.000194	0.00131	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—NOS3—systemic scleroderma	0.000187	0.00126	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—NOS3—systemic scleroderma	0.000163	0.0011	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—NOS3—systemic scleroderma	0.000163	0.0011	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—NOS3—systemic scleroderma	0.000163	0.0011	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—TGFB1—systemic scleroderma	0.000147	0.000993	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TGFB1—systemic scleroderma	0.000145	0.000976	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—NOS3—systemic scleroderma	0.000131	0.000886	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—TGFB1—systemic scleroderma	0.000129	0.000868	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—NOS3—systemic scleroderma	0.00012	0.00081	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—NOS3—systemic scleroderma	9.36e-05	0.000631	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NOS3—systemic scleroderma	9.36e-05	0.000631	CbGpPWpGaD
